Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)
geptanolimab (GB226) 治疗复发或难治性外周 T 细胞淋巴瘤的疗效和安全性:一项开放标签 2 期研究 (Gxplore-002)
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-021-01033-1
Shi, Yuankai; Wu, Jianqiu; Wang, Zhen; Zhang, Liling; Wang, Zhao; Zhang, Mingzhi; Cen, Hong; Peng, Zhigang; Li, Yufu; Fan, Lei; Guo, Ye; Ma, Liping; Cui, Jie; Gao, Yuhuan; Yang, Haiyan; Zhang, Hongyu; Wang, Lin; Zhang, Weihua; Zhang, Huilai; Xie, Liping; Jiang, Ming; Zhou, Hui; Shuang, Yuerong; Su, Hang; Ke, Xiaoyan; Jin, Chuan; Du, Xin; Du, Xin; Liu, Li; Xi, Yaming; Ge, Zheng; Feng, Ru; Zhang, Yang; Zhou, Shengyu; Xie, Fan; Wang, Qian